Literature DB >> 18411084

Mammosomatotropes: current status and possible functions.

L S Frawley1.   

Abstract

Recent studies show that mammosomatotropes-cells that secrete both growth hormone and prolactin-are common in normal pituitary tissue. It is proposed that these dual hormone secretors serve as transitional cells for the differentiation of classical mammotropes during development, and for the functional interconversion of growth hormone and prolactin secretors in adults.

Entities:  

Year:  1989        PMID： 18411084     DOI： 10.1016/1043-2760(89)90027-1

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN： 1043-2760            Impact factor:   12.015


  6 in total

Review 1.  Human pituitary adenomas. Recent advances in morphological studies.

Authors:  G Giannattasio; M Bassetti
Journal:  J Endocrinol Invest       Date:  1990-05       Impact factor: 4.256

Review 2.  Prolactin and mammary gland development.

Authors:  N D Horseman
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-01       Impact factor: 2.673

3.  Endothelin-like immunoreactivity in lactotrophs, gonadotrophs, and somatotrophs of rat anterior pituitary gland are affected differentially by ovarian steroid hormones.

Authors:  B Kanyicska; A Lerant; M E Freeman
Journal:  Endocrine       Date:  2001-03       Impact factor: 3.633

Review 4.  Molecular determinants of pituitary cytodifferentiation.

Authors:  S L Asa; S Ezzat
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

5.  The mammosomatotroph: a transitional cell between growth hormone and prolactin producing cells? An immunocytochemical study.

Authors:  H A Pasolli; A I Torres; A Aoki
Journal:  Histochemistry       Date:  1994-10

6.  Pulsatile patterns of pituitary hormone gene expression change during development.

Authors:  Karen Featherstone; Claire V Harper; Anne McNamara; Sabrina Semprini; David G Spiller; Judith McNeilly; Alan S McNeilly; John J Mullins; Michael R H White; Julian R E Davis
Journal:  J Cell Sci       Date:  2011-10-07       Impact factor: 5.285
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.